DNA Vaccine tagged posts

DNA Vaccine Protects against Toxic Proteins linked to Alzheimer’s

DNA vaccine protects against toxic proteins linked to Alzheimer's

UT Southwestern researchers have developed a DNA vaccine that helps the body protect against toxic proteins associated with Alzheimer’s disease. These images show amyloid plaque in the mouse brain using plasma containing anti-amyloid antibody from large mammals immunized with the vaccine. Credit: UT Southwestern

A new DNA vaccine when delivered to the skin prompts an immune response that produces antibodies to protect against toxic proteins associated with Alzheimer’s disease – without triggering severe brain swelling that earlier antibody treatments caused in some patients. Two studies from the Peter O’Donnell Jr. Brain Institute demonstrate in animals how a vaccine containing DNA of the toxic beta-amyloid protein elicits a different immune response that may be safe for humans...

Read More

A novel DNA Vaccine design improves chances of inducing Anti-Tumor Immunity

Anti-tumor Immunity Elicited by pSynConWT1-S(A) Mice were challenged with 106 ...

Anti-tumor Immunity Elicited by pSynConWT1-S (A) Mice were challenged with 106 mWT1-C1498 tumor cells injected subcutaneously and were vaccinated weekly starting 3 days post-tumor implant. Tumor measurements are reported in terms of tumor volume only for surviving mice until day 28. (B) Survival data from the tumor therapeutic challenge in (A). Vaccination with pSynConWT1-S extended survival in tumor-bearing mice. (C) Representative image of tumor size in naive or pSynConWT1-S vaccinated groups at day 14 post-mWT1-C1498 implantation. Error bars represent the average ± SEM.

Scientists at The Wistar Institute and Inovio Pharmaceuticals, Inc...

Read More

Genetically Engineered DNA Vaccine Eradicates High-Grade Precancerous Cervical Lesions in nearly 1/2 of women in clinical trial

DNA Vaccine

The goal was to find nonsurgical ways to treat precancerous lesions caused by HPV. “Every standard therapeutic option for women with these lesions destroys part of the cervix, which is particularly relevant for women of childbearing age, who may then be at risk for preterm birth due to a weakened cervix,” says Prof. Cornelia Trimble, M.D. “A vaccine able to cure precancerous lesions could eventually be one way women can avoid surgery that is invasive and can also harm their fertility.”

High-grade cervical lesions, termed CIN2/3, occur most often in women 40 or younger. Because the lesions can progress to cancer, they are usually removed by surgery, freezing or laser. The procedures are successful in removing the precancerous areas in approximately 80% of women...

Read More